Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Expensive Rx Drugs Put Spotlight On OTC Opportunity – Economist

This article was originally published in The Tan Sheet

Executive Summary

Over-the-counter drug firms have a promising opportunity to market their products as alternatives to Rx drugs for consumers confronted with coverage gaps in Medicare Part D and private insurance plans, a Princeton University economics and public affairs professor advised industry executives

You may also be interested in...



Pharmacists’ Regard Grows For OTCs As Rx Alternatives, APhA Officer Says

Both pharmacists and consumers are paying increasing attention to the use of some OTCs as a solution to the Medicare Part D "coverage gap," according to Timothy L. Tucker, president-elect of the American Pharmacists Association

Pharmacists’ Regard Grows For OTCs As Rx Alternatives, APhA Officer Says

Both pharmacists and consumers are paying increasing attention to the use of some OTCs as a solution to the Medicare Part D "coverage gap," according to Timothy L. Tucker, president-elect of the American Pharmacists Association

Pharmacists’ Regard Grows For OTCs As Rx Alternatives, APhA Officer Says

Both pharmacists and consumers are paying increasing attention to the use of some OTCs as a solution to the Medicare Part D "coverage gap," according to Timothy L. Tucker, president-elect of the American Pharmacists Association

Related Content

Topics

UsernamePublicRestriction

Register

PS100355

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel